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Synopsis 
Muscle development involves concerted action of a repertoire of mechanisms 
governing myoblast proliferation, migration, fusion and differentiation. Subsequently, 
there are cellular events administrating proper muscle function and maintenance of 
muscle integrity. Chapter 1 covers what is known about muscle development, 
building up of mass and maintenance in vertebrates and Drosophila, highlighting the 
myogenic programs and factors that play a role in them. The formation of vertebrate 
skeletal muscles can be recapitulated in Drosophila indirect flight muscles (IFMs), 
making IFMs an interesting model to dissect and understand the mechanisms of 
muscle development and maintenance. The cellular and developmental events that 
occur during IFM development have been discussed in detail along with their genetic 
control which encompasses both cell autonomous and cell non-autonomous 
mechanisms. The fly resources and tools used for experimentations have been 
described in Chapter 2. 
One of the hallmark events during muscle development is myoblast fusion. 
Myoblasts are kept in undifferentiated state until they fuse through a balanced action 
of anti-differentiation and pro-differentiation factors. The swarming myoblasts are in 
semi-differentiated state and just prior to fusion should exit cell cycle to achieve 
terminal differentiation. The mechanisms of cyclin/CDK complexes and their 
regulation via CKI (CDK inhibitor) are known in a cell. However, tissue specific 
factors exerting additional control on molecules that participate in cell cycle have 
been proposed but have not been shown in vivo. Chapter 3 uncovers a novel role 
played by the transcription factor, Erect wing (Ewg) in IFM development and 
patterning. Despite the fact that Ewg is known to express in fusing myoblasts and 
nuclei of developing IFMs and has long been used as a nuclear marker for IFMs, the 
mechanism(s) behind Ewg‟s function has remained enigmatic. Historical perspective 
of Ewg has been presented in Chapter 1. One set of IFMs; dorsal longitudinal 
muscles (DLMs) require larval templates for their formation and the other set; dorsal 
ventral muscles (DVMs) form de novo. Chapter 3 shows that Ewg is required in a 
spatio-temporal fashion to initiate myoblast fusion process. In the absence of Ewg, the 
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number of fusion events in a given time is reduced. In addition de novo fusion is 
observed in the region of DLM development just like DVM and overall IFM 
development is delayed resulting in an aberrant adult IFM pattern. Genetic studies 
undertaken reveal a requirement for Ewg in exerting a temporal control on myoblast 
fusion. This is achieved by down-regulating Cyclin E levels, as a result of which the 
myoblasts exit cell cycle at G1/S stage. Through this study the proposal for DLM 
development and pattern has been put forth as follows: i) appropriate progression of 
DLM development commences on synchronous exit of myoblasts from cell cycle. 
This function is facilitated by Ewg expression in fusing myoblasts assisting 
symmetrical DLM formation in hemithoraces. ii) DLM pattern of six muscles in each 
hemithorax is dependent on template survival which requires fusion of enough 
myoblasts and further subsequent fusion events to support the splitting of three larval 
templates or presumptive DLM. 
The muscles that develop should preserve their structural integrity for efficient 
functional output. Muscles perform extensive activities warranting high energy 
requirements. IFMs are widely utilised for thorax movements that aid flight. IFMs are 
exclusively oxidative in nature with upto 40% mass contributed by large mitochondria 
themselves. Chapter 4 describes yet another novel finding for Ewg function in IFM 
maintenance. Vertebrate homolog of Ewg is nuclear respiratory factor 1 (NRF1) 
known for its role in mitochondrial biogenesis. This prompted an investigation on the 
role of Ewg, if any, in mitochondrial function and IFM maintenance. In this chapter, 
Ewg null adult IFMs are shown to undergo degeneration. Mitochondria in these 
muscles show rounder and smaller phenotype. Mitochondria morphology is traced 
throughout Drosophila pupal DLM development and extensive fusion is observed in 
last one-fourth of pupal phase. In Ewg null condition transcripts of Opa1-like required 
for inner mitochondrial membrane fusion is found to be absent, suggesting lack of 
mitochondrial fusion behind the smaller mitochondrial morphology. This emerged as 
an intriguing problem since Ewg expression follows until sarcomerogenesis 
(formation of sarcomeres) initiates at mid pupal stage. Developmentally extending 
Ewg‟s expression beyond mid pupal stage is not observed to increase Opa1-like levels 
pointing an indirect regulation by Ewg. However, Opa1-like knock-down beyond mid 
pupal stage is not observed to result in any muscle or flight defect. It is thus proposed 
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that Ewg expression early during muscle development helps to up-regulate Opa1-like 
levels needed to support mitochondrial growth and fusion. In addition, this chapter 
provides additional data on requirement of Opa1-like for maintenance of 
mitochondrial as well as muscle integrity. This is the first ever report of tissue specific 
temporal regulation of Opa1-like by Ewg. 
Chapter 3 and Chapter 4 conclude spatially segregated functional 
requirements of Ewg which are also mechanistically distinct. Expression in fusing 
myoblasts channelizes fusing myoblasts to exit cell cycle and undergo timely fusion 
saving the larval template, subsequent fusion assists template splitting thus forming 
the appropriate adult DLM pattern. On the other hand expression until mid pupal 
stage up-regulates Opa1-like expression, facilitating mitochondrial fusion during the 
late pupal stage. This as a result helps maintain structural integrity of muscles in the 
adult.  
Vertebrate skeletal muscle contains multiple muscle fibres that provide 
appropriate mass and size to muscles. As DLM share similarity in development to that 
of the vertebrate skeletal muscle, DLM organisation is studied to get insights into the 
mechanisms which regulate the process. Chapter 5 discusses role of nuclear number 
and nuclear activity in determining the DLM organisation. In order to alter nuclear 
number, myoblast population is reduced to amounts lesser than that of the wild type 
and to alter nuclear activity, two nuclear encoded genes Opa1-like and Marf , 
involved in inner and outer mitochondrial membrane fusion respectively have been 
knocked down in IFMs. First, the DLM organisation is established by comparing it to 
the vertebrate skeletal muscle organisation. This organisation is affected on lowering 
the number of myoblasts destined to fuse and form IFMs, without affecting the 
differentiation. On the other hand, when nuclear encoded mitochondrial fusion genes 
are knocked down, not only DLM organisation but their differentiation is also 
affected. A proposal for achieving DLM organisation has been presented which 
should also apply to vertebrate skeletal muscle given their developmental similarity. 
In conclusion, the studies decipher a novel mechanism by which a 
transcription factor, Ewg exerts a temporal control on myoblast fusions directly 
influencing progression of DLM formation, and thereby, symmetry and pattern. 
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Moreover, Ewg is also shown here to regulate mitochondrial fusion during later pupal 
stages helping muscles to attain greater function and maintain structural integrity. 
Discovery of such regulatory mechanisms controlling mitochondrial dynamics in 
vertebrates can open up new avenues to understand and design new therapeutic 
approaches to tackle mitochondrial diseases. Additionally, myoblast fusion and hence 
myonuclear number and their efficient functioning are shown to be important 
determinants of muscle organisation. This has further implications in understanding 
and using stem cell science in dystrophic or atrophic or ageing related muscle loss and 
therapy. 
